Fabrizio
D'Ascenzo
Publications by the researcher in collaboration with Fabrizio D'Ascenzo (48)
2024
-
Corrigendum to ‘Forecasting the Risk of Heart Failure Hospitalization After Acute Coronary Syndromes: the CORALYS HF Score’ [American Journal of Cardiology 206 (2023) 320-329, (S000291492300766X), (10.1016/j.amjcard.2023.08.010)]
American Journal of Cardiology
-
Gender differences in the development of heart failure after acute coronary syndrome: Insight from the CORALYS registry
International Journal of Cardiology, Vol. 397
-
Long-term impact of intravascular ultrasound-guidance for percutaneous coronary intervention on unprotected left main. The IMPACTUS-LM, an observational, multicentric study
International Journal of Cardiology, Vol. 401
2023
-
Forecasting the Risk of Heart Failure Hospitalization After Acute Coronary Syndromes: the CORALYS HF Score
American Journal of Cardiology, Vol. 206, pp. 320-329
-
Impact of Complete Revascularization on Development of Heart Failure in Patients With Acute Coronary Syndrome and Multivessel Disease: A Subanalysis of the CORALYS Registry
Journal of the American Heart Association, Vol. 12, Núm. 15, pp. e028475
-
Impact of Right Ventricular Pacing in Patients With TAVR Undergoing Permanent Pacemaker Implantation
JACC: Cardiovascular Interventions, Vol. 16, Núm. 9, pp. 1081-1091
-
IncidenCe and predictOrs of heaRt fAiLure after acute coronarY Syndrome: The CORALYS registry
International Journal of Cardiology, Vol. 370, pp. 35-42
-
Optimal medical therapy improves outcomes in patients with diabetes mellitus and acute myocardial infarction
Diabetes Research and Clinical Practice, Vol. 203
-
Predictors of target lesion failure after treatment of left main, bifurcation, or chronic total occlusion lesions with ultrathin-strut drug-eluting coronary stents in the ULTRA registry
Catheterization and Cardiovascular Interventions, Vol. 102, Núm. 2, pp. 221-232
2022
-
Ischemic-hemorrhagic balance in diabetic and non-diabetic patients after acute coronary syndrome
REC: CardioClinics, Vol. 57, Núm. 3, pp. 203-211
-
Safety and efficacy of different P2Y12 inhibitors in patients with acute coronary syndromes stratified by the PRAISE risk score: a multicentre study
European heart journal. Quality of care & clinical outcomes, Vol. 8, Núm. 8, pp. 881-891
2021
-
Atrial fibrillation in patients with COVID-19. Usefulness of the CHA2DS2-VASc score: an analysis of the international HOPE COVID-19 registry
Revista Espanola de Cardiologia, Vol. 74, Núm. 7, pp. 608-615
-
Evaluation of optimal medical therapy in acute myocardial infarction patients with prior stroke
Therapeutic Advances in Chronic Disease, Vol. 12
-
Long-term (≥15 years) Follow-up of Percutaneous Coronary Intervention of Unprotected Left Main (From the GRAVITY Registry)
American Journal of Cardiology, Vol. 156, pp. 72-78
-
Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets
The Lancet, Vol. 397, Núm. 10270, pp. 199-207
-
Mortality risk assessment in Spain and Italy, insights of the HOPE COVID-19 registry
Internal and Emergency Medicine, Vol. 16, Núm. 4, pp. 957-966
-
Ticagrelor or Clopidogrel After an Acute Coronary Syndrome in the Elderly: A Propensity Score Matching Analysis from 16,653 Patients Treated with PCI Included in Two Large Multinational Registries
Cardiovascular Drugs and Therapy, Vol. 35, Núm. 6, pp. 1171-1182
-
Ticagrelor versus prasugrel in acute coronary syndrome: sex-specific analysis from the RENAMI Registry
Minerva cardiology and angiology, Vol. 69, Núm. 4, pp. 408-416
-
Underlying heart diseases and acute covid-19 outcomes
Cardiology Journal, Vol. 28, Núm. 2, pp. 202-214